WallStreetZenWallStreetZen

NASDAQ: AKYA
Akoya Biosciences Inc Stock

$1.97+0.03 (+1.55%)
Updated May 24, 2024
AKYA Price
$1.97
Fair Value Price
N/A
Market Cap
$97.04M
52 Week Low
$1.88
52 Week High
$8.80
P/E
-1.36x
P/B
2.97x
P/S
2.47x
PEG
N/A
Dividend Yield
N/A
Revenue
$93.57M
Earnings
-$68.01M
Gross Margin
56%
Operating Margin
-62.64%
Profit Margin
-72.7%
Debt to Equity
3.73
Operating Cash Flow
-$52M
Beta
1.48
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

AKYA Overview

Akoya Biosciences, Inc. provides spatial biology solutions focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, which helps to understand disease progression and patient responses to therapy. Its flagship products include PhenoCycler, PhenoImager, and PhenoImager HT. The company was incorporated in 2015 and is headquartered in Marlborough, MA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AKYA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AKYA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AKYA is good value based on its book value relative to its share price (2.97x), compared to the US Medical Instruments & Supplies industry average (3.59x)
P/B vs Industry Valuation
AKYA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AKYA due diligence checks available for Premium users.

Be the first to know about important AKYA news, forecast changes, insider trades & much more!

AKYA News

Valuation

AKYA fair value

Fair Value of AKYA stock based on Discounted Cash Flow (DCF)
Price
$1.97
Fair Value
$6.11
Undervalued by
67.74%
AKYA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AKYA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.36x
Industry
57.91x
Market
32.03x

AKYA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.97x
Industry
3.59x
AKYA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AKYA's financial health

Profit margin

Revenue
$18.4M
Net Income
-$23.5M
Profit Margin
-128%
AKYA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AKYA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$154.8M
Liabilities
$122.0M
Debt to equity
3.73
AKYA's short-term assets ($101.83M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AKYA's short-term assets ($101.83M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AKYA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$20.8M
Investing
-$48.8M
Financing
-$444.0k
AKYA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AKYA vs Medical Stocks

TickerMarket Cap1d %P/EP/B
AKYA$97.04M+1.29%-1.36x2.97x
KRMD$100.68M+0.46%-7.86x5.27x
ZTEK$108.93M-2.61%-13.33x6.54x
BNGO$71.54M+3.88%-0.18x0.86x
PDEX$67.49M+1.13%16.05x2.18x

Akoya Biosciences Stock FAQ

What is Akoya Biosciences's quote symbol?

(NASDAQ: AKYA) Akoya Biosciences trades on the NASDAQ under the ticker symbol AKYA. Akoya Biosciences stock quotes can also be displayed as NASDAQ: AKYA.

If you're new to stock investing, here's how to buy Akoya Biosciences stock.

What is the 52 week high and low for Akoya Biosciences (NASDAQ: AKYA)?

(NASDAQ: AKYA) Akoya Biosciences's 52-week high was $8.80, and its 52-week low was $1.88. It is currently -77.67% from its 52-week high and 4.52% from its 52-week low.

How much is Akoya Biosciences stock worth today?

(NASDAQ: AKYA) Akoya Biosciences currently has 49,386,247 outstanding shares. With Akoya Biosciences stock trading at $1.97 per share, the total value of Akoya Biosciences stock (market capitalization) is $97.04M.

Akoya Biosciences stock was originally listed at a price of $26.05 in Apr 16, 2021. If you had invested in Akoya Biosciences stock at $26.05, your return over the last 3 years would have been -92.46%, for an annualized return of -57.75% (not including any dividends or dividend reinvestments).

How much is Akoya Biosciences's stock price per share?

(NASDAQ: AKYA) Akoya Biosciences stock price per share is $1.97 today (as of May 24, 2024).

What is Akoya Biosciences's Market Cap?

(NASDAQ: AKYA) Akoya Biosciences's market cap is $97.04M, as of May 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Akoya Biosciences's market cap is calculated by multiplying AKYA's current stock price of $1.97 by AKYA's total outstanding shares of 49,386,247.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.